Russell Investments Group Ltd. trimmed its position in Syneos Health, Inc. (NASDAQ:SYNH – Get Rating) by 47.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned